The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global AFP Testing Market Research Report 2025
Synopsis
Alpha-fetoprotein (AFP) is a protein produced in the liver of a developing fetus.
The global AFP Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AFP Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AFP Testing.
Report Scope
The AFP Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AFP Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AFP Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton Dickinson
Biomedical Diagnostics
Bio-Rad Laboratories
Beckman Coulter
Roche Diagnostics
Kreatech Diagnostics
Mackay Life Sciences
Siemens Healthcare
Panacea Pharmaceuticals
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Biliary Tract Cancer
Stomach Cancer
Pancreatic Cancer
Others
Segment by Application
Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AFP Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Alpha-fetoprotein (AFP) is a protein produced in the liver of a developing fetus.
The global AFP Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for AFP Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AFP Testing.
Report Scope
The AFP Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AFP Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AFP Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton Dickinson
Biomedical Diagnostics
Bio-Rad Laboratories
Beckman Coulter
Roche Diagnostics
Kreatech Diagnostics
Mackay Life Sciences
Siemens Healthcare
Panacea Pharmaceuticals
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Biliary Tract Cancer
Stomach Cancer
Pancreatic Cancer
Others
Segment by Application
Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AFP Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AFP Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liver Cancer
1.2.3 Testes Cancer
1.2.4 Ovarian Cancer
1.2.5 Biliary Tract Cancer
1.2.6 Stomach Cancer
1.2.7 Pancreatic Cancer
1.2.8 Others
1.3 Market by Application
1.3.1 Global AFP Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AFP Testing Market Perspective (2019-2030)
2.2 AFP Testing Growth Trends by Region
2.2.1 Global AFP Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AFP Testing Historic Market Size by Region (2019-2024)
2.2.3 AFP Testing Forecasted Market Size by Region (2025-2030)
2.3 AFP Testing Market Dynamics
2.3.1 AFP Testing Industry Trends
2.3.2 AFP Testing Market Drivers
2.3.3 AFP Testing Market Challenges
2.3.4 AFP Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AFP Testing Players by Revenue
3.1.1 Global Top AFP Testing Players by Revenue (2019-2024)
3.1.2 Global AFP Testing Revenue Market Share by Players (2019-2024)
3.2 Global AFP Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AFP Testing Revenue
3.4 Global AFP Testing Market Concentration Ratio
3.4.1 Global AFP Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AFP Testing Revenue in 2023
3.5 AFP Testing Key Players Head office and Area Served
3.6 Key Players AFP Testing Product Solution and Service
3.7 Date of Enter into AFP Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AFP Testing Breakdown Data by Type
4.1 Global AFP Testing Historic Market Size by Type (2019-2024)
4.2 Global AFP Testing Forecasted Market Size by Type (2025-2030)
5 AFP Testing Breakdown Data by Application
5.1 Global AFP Testing Historic Market Size by Application (2019-2024)
5.2 Global AFP Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AFP Testing Market Size (2019-2030)
6.2 North America AFP Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AFP Testing Market Size by Country (2019-2024)
6.4 North America AFP Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AFP Testing Market Size (2019-2030)
7.2 Europe AFP Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AFP Testing Market Size by Country (2019-2024)
7.4 Europe AFP Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AFP Testing Market Size (2019-2030)
8.2 Asia-Pacific AFP Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AFP Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific AFP Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AFP Testing Market Size (2019-2030)
9.2 Latin America AFP Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AFP Testing Market Size by Country (2019-2024)
9.4 Latin America AFP Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AFP Testing Market Size (2019-2030)
10.2 Middle East & Africa AFP Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AFP Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa AFP Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories AFP Testing Introduction
11.1.4 Abbott Laboratories Revenue in AFP Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Detail
11.2.2 Becton Dickinson Business Overview
11.2.3 Becton Dickinson AFP Testing Introduction
11.2.4 Becton Dickinson Revenue in AFP Testing Business (2019-2024)
11.2.5 Becton Dickinson Recent Development
11.3 Biomedical Diagnostics
11.3.1 Biomedical Diagnostics Company Detail
11.3.2 Biomedical Diagnostics Business Overview
11.3.3 Biomedical Diagnostics AFP Testing Introduction
11.3.4 Biomedical Diagnostics Revenue in AFP Testing Business (2019-2024)
11.3.5 Biomedical Diagnostics Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories AFP Testing Introduction
11.4.4 Bio-Rad Laboratories Revenue in AFP Testing Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter AFP Testing Introduction
11.5.4 Beckman Coulter Revenue in AFP Testing Business (2019-2024)
11.5.5 Beckman Coulter Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Detail
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics AFP Testing Introduction
11.6.4 Roche Diagnostics Revenue in AFP Testing Business (2019-2024)
11.6.5 Roche Diagnostics Recent Development
11.7 Kreatech Diagnostics
11.7.1 Kreatech Diagnostics Company Detail
11.7.2 Kreatech Diagnostics Business Overview
11.7.3 Kreatech Diagnostics AFP Testing Introduction
11.7.4 Kreatech Diagnostics Revenue in AFP Testing Business (2019-2024)
11.7.5 Kreatech Diagnostics Recent Development
11.8 Mackay Life Sciences
11.8.1 Mackay Life Sciences Company Detail
11.8.2 Mackay Life Sciences Business Overview
11.8.3 Mackay Life Sciences AFP Testing Introduction
11.8.4 Mackay Life Sciences Revenue in AFP Testing Business (2019-2024)
11.8.5 Mackay Life Sciences Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Detail
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare AFP Testing Introduction
11.9.4 Siemens Healthcare Revenue in AFP Testing Business (2019-2024)
11.9.5 Siemens Healthcare Recent Development
11.10 Panacea Pharmaceuticals
11.10.1 Panacea Pharmaceuticals Company Detail
11.10.2 Panacea Pharmaceuticals Business Overview
11.10.3 Panacea Pharmaceuticals AFP Testing Introduction
11.10.4 Panacea Pharmaceuticals Revenue in AFP Testing Business (2019-2024)
11.10.5 Panacea Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
